Kim Kelderman Power - 15 Aug 2026 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
02 Nov 2026, 16:35:41 UTC
Original report date
18 Aug 2026
Prior SEC filing
30 Jul 2026
Next SEC filing
19 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Filing notes and source

Key filing fact

Kim Kelderman Power filed Form 4/A - Amendment for BIO-TECHNE Corp (TECH) on 02 Nov 2026.

Key facts

  • This page summarizes Kim Kelderman Power's Form 4/A - Amendment filing for BIO-TECHNE Corp (TECH).
  • 10 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2026, 16:35.

Change

  • Previous filing in this sequence was filed on 30 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001739054 Primary reporting owner

Kelderman Kim

Relationship
Chief Executive Officer, Director
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares
+21,736
Change %
+30%
Price
$0.000000*
Shares after
93,849
Date
15 Aug 2026
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
Shares
-10,955
Change %
-12%
Price
$72.40*
Shares after
82,894
Date
15 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Performance Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-22,044
Change %
-92%
Price
$0.000000*
Shares after
1,837
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,044
Exercise price
$84.61
Footnotes
F1
TECH transaction Derivative

Performance Stock Options (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-23,949
Change %
-92%
Price
$0.000000*
Shares after
1,996
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,949
Exercise price
$68.54
Footnotes
F2
TECH transaction Derivative

Performance Restricted Stock Units

Options Exercise

Transaction value
Shares
-683
Change %
-7.7%
Price
$0.000000*
Shares after
8,190
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
683
Exercise price
Footnotes
F3, F4
TECH transaction Derivative

Performance Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-8,190
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,190
Exercise price
Footnotes
F3, F4
TECH transaction Derivative

Performance Restricted Stock Units

Options Exercise

Transaction value
Shares
-725
Change %
-7.7%
Price
$0.000000*
Shares after
8,698
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
725
Exercise price
Footnotes
F3, F5
TECH transaction Derivative

Performance Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-8,698
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,698
Exercise price
Footnotes
F3, F5
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-8,543
Change %
-50%
Price
$0.000000*
Shares after
8,544
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,543
Exercise price
Footnotes
F3, F6
TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-11,785
Change %
-33%
Price
$0.000000*
Shares after
23,569
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,785
Exercise price
Footnotes
F3, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited.

Footnote F2

On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F4

On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited.

Footnote F5

On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited.

Footnote F6

8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.

Footnote F7

11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .